127 related articles for article (PubMed ID: 12045455)
1. Acronycine derivatives as promising antitumor agents.
Guilbaud N; Léonce S; Tillequin F; Koch M; Hickman JA; Pierré A
Anticancer Drugs; 2002 Jun; 13(5):445-9. PubMed ID: 12045455
[TBL] [Abstract][Full Text] [Related]
2. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
[TBL] [Abstract][Full Text] [Related]
3. Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis.
Léonce S; Pérez V; Lambel S; Peyroulan D; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman JA; Pierré A
Mol Pharmacol; 2001 Dec; 60(6):1383-91. PubMed ID: 11723246
[TBL] [Abstract][Full Text] [Related]
4. [Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents].
Seguin E; Tillequin F
Ann Pharm Fr; 2005 Jan; 63(1):44-52. PubMed ID: 15803100
[TBL] [Abstract][Full Text] [Related]
5. [New antitumor agents in the acronycine series].
Tillequin F
Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
[TBL] [Abstract][Full Text] [Related]
6. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
Koch M
Bull Acad Natl Med; 2007 Jan; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
[TBL] [Abstract][Full Text] [Related]
7. Design of novel antitumor DNA alkylating agents: the benzacronycine series.
David-Cordonnier MH; Laine W; Gaslonde T; Michel S; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):83-92. PubMed ID: 15032716
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Pfeiffer B; Renard P; Kraus-Berthier L; Léonce S; Pierré A
Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):293-7. PubMed ID: 14993749
[TBL] [Abstract][Full Text] [Related]
9. Acronycine derivatives: a promising series of anticancer agents.
Nguyen QC; Nguyen TT; Yougnia R; Gaslonde T; Dufat H; Michel S; Tillequin F
Anticancer Agents Med Chem; 2009 Sep; 9(7):804-15. PubMed ID: 19594412
[TBL] [Abstract][Full Text] [Related]
10. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
Depauw S; Gaslonde T; Léonce S; Kraus-Berthier L; Laine W; Lenglet G; Chiaroni A; Pfeiffer B; Bailly C; Michel S; Tillequin F; Pierré A; David-Cordonnier MH
Mol Pharmacol; 2009 Dec; 76(6):1172-85. PubMed ID: 19752199
[TBL] [Abstract][Full Text] [Related]
11. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
Michel S; Gaslonde T; Tillequin F
Eur J Med Chem; 2004 Aug; 39(8):649-55. PubMed ID: 15276298
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in HL-60 leukemia and B16 melanoma cells by the acronycine derivative S23906-1.
Kluza J; Lansiaux A; Wattez N; Hildebrand MP; Léonce S; Pierré A; Hickman JA; Bailly C
Biochem Pharmacol; 2002 Apr; 63(8):1443-52. PubMed ID: 11996885
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the cytotoxic mechanisms mediated by the broad-spectrum antitumor alkaloid acronycine and selected semisynthetic derivatives.
Shieh HL; Pezzuto JM; Cordell GA
Chem Biol Interact; 1992 Jan; 81(1-2):35-55. PubMed ID: 1730147
[TBL] [Abstract][Full Text] [Related]
14. Alkylation of guanine in DNA by S23906-1, a novel potent antitumor compound derived from the plant alkaloid acronycine.
David-Cordonnier MH; Laine W; Lansiaux A; Kouach M; Briand G; Pierré A; Hickman JA; Bailly C
Biochemistry; 2002 Aug; 41(31):9911-20. PubMed ID: 12146956
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
Do Q; Tian W; Yougnia R; Gaslonde T; Pfeiffer B; Pierré A; Léonce S; Kraus-Berthier L; David-Cordonnier MH; Depauw S; Lansiaux A; Mazinghien R; Koch M; Tillequin F; Michel S; Dufat H
Bioorg Med Chem; 2009 Mar; 17(5):1918-27. PubMed ID: 19217791
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships in the acronycine series.
Michel S; Seguin E; Tillequin F
Curr Med Chem; 2002 Sep; 9(18):1689-700. PubMed ID: 12171551
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
Do Q; Thi Mai HD; Gaslonde T; Pfeiffer B; Léonce S; Pierré A; Michel S; Tillequin F; Dufat H
Eur J Med Chem; 2008 Dec; 43(12):2677-87. PubMed ID: 18342404
[TBL] [Abstract][Full Text] [Related]
18. [Acronycine revisited: development of benzo[b]acronycine antitumor agents].
Tillequin F; Koch M
Ann Pharm Fr; 2005 Jan; 63(1):35-43. PubMed ID: 15803099
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.
Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Atassi G
J Nat Prod; 1998 Feb; 61(2):198-201. PubMed ID: 9514007
[TBL] [Abstract][Full Text] [Related]
20. Covalent binding to glutathione of the DNA-alkylating antitumor agent, S23906-1.
David-Cordonnier MH; Laine W; Joubert A; Tardy C; Goossens JF; Kouach M; Briand G; Thi Mai HD; Michel S; Tillequin F; Koch M; Leonce S; Pierre A; Bailly C
Eur J Biochem; 2003 Jul; 270(13):2848-59. PubMed ID: 12823555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]